Eur Respir J 2002; 20:1228-1232
Copyright ©ERS Journals Ltd 2002
Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice
S.S. Lok1,
Y. Haider1,
D. Howell2,
J.P. Stewart3,
P.S. Hasleton2 and
J.J. Egan4
1 North West Lung Research Centre, Wythenshawe Hospital, Southmoor Road, Manchester, 2 Raynes Institute, University College London, London, 3 Dept of Veterinary Pathology, University of Edinburgh, Summerhall, Edinburgh, and 4 The Mater Misericordiae Hospital, Eccles Street, Dublin, Ireland, UK
CORRESPONDENCE: J.J. Egan, Dept of Respiratory Medicine, The Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland. Fax: 35 316605451. E-mail: jegan@mater.ie
Keywords: bleomycin, murine gammaherpes virus, pulmonary fibrosis
Received: August 21, 2001
Accepted March 22, 2002
Studies of human tissue have suggested an association between productive Epstein Barr virus and idiopathic pulmonary fibrosis (IPF). However, a pathogenic role for the virus has not been established. This study was undertaken to develop an animal model, which would explore the association between viral infection and pulmonary fibrosis.
BALB/c mice (n=30), resistant to bleomycin, were primed with murine gammaherpesvirus 68 and then given intraperitoneal bleomycin. The mice were sacrificed at 28 days after bleomycin and their lungs assessed histologically and biochemically. Lung pathology was scored 03 for fibrotic and inflammatory change.
BALB/c mice given virus and bleomycin showed more lung fibrosis (median score 2.2) compared to those given bleomycin alone (median 0), virus alone (median 0.2) or phosphate-buffered saline (PBS) control (median 0). Similarly mice given both virus and bleomycin showed more lung inflammation (median score 1.9) compared to those given bleomycin (median 0.5), virus (median 0.8), or PBS control (median 0.2). There was a significant difference in collagen content between the bleomycin and virus group (mean 1.86 mg) compared to the belomycin alone group (mean 1.52 mg).
These results suggest that virus alone does not result in pulmonary fibrosis but that replicating virus in the presence of an exogenous injury may promote the development of pulmonary fibrosis.
This article has been cited by other articles:

|
 |

|
 |
 
W. D. Hardie, S. W. Glasser, and J. S. Hagood
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Am. J. Pathol.,
July 1, 2009;
175(1):
3 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Malizia, D. T. Keating, S. M. Smith, D. Walls, P. P. Doran, and J. J. Egan
Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGF{beta}1 expression
Am J Physiol Lung Cell Mol Physiol,
September 1, 2008;
295(3):
L451 - L460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. McMillan, B. B. Moore, J. B. Weinberg, K. M. Vannella, W. B. Fields, P. J. Christensen, L. F. van Dyk, and G. B. Toews
Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus
Am. J. Respir. Crit. Care Med.,
April 1, 2008;
177(7):
771 - 780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore and C. M. Hogaboam
Murine models of pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L152 - L160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Williams, R. Maes, F. Del Piero, A. Lim, A. Wise, D. C. Bolin, J. Caswell, C. Jackson, N. E. Robinson, F. Derksen, et al.
Equine Multinodular Pulmonary Fibrosis: A Newly Recognized Herpesvirus-Associated Fibrotic Lung Disease
Vet. Pathol.,
November 1, 2007;
44(6):
849 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Center
Taking the "Idio" Out of Idiopathic Pulmonary Fibrosis: A Call to Arms
Am. J. Respir. Crit. Care Med.,
June 1, 2007;
175(11):
1101 - 1102.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Selman and A. Pardo
Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.
Proceedings of the ATS,
January 1, 2006;
3(4):
364 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Torrero, W. G. Henk, and S. Li
Regression of High-Grade Malignancy in Mice by Bleomycin and Interleukin-12 Electrochemogenetherapy
Clin. Cancer Res.,
January 1, 2006;
12(1):
257 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Katano and C. M. Hogaboam
Herpesvirus-associated Pulmonary Hypertension?
Am. J. Respir. Crit. Care Med.,
December 15, 2005;
172(12):
1485 - 1486.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Doran and J. J. Egan
Herpesviruses: a cofactor in the pathogenesis of idiopathic pulmonary fibrosis?
Am J Physiol Lung Cell Mol Physiol,
November 1, 2005;
289(5):
L709 - L710.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Mora, C. R. Woods, A. Garcia, J. Xu, M. Rojas, S. H. Speck, J. Roman, K. L. Brigham, and A. A. Stecenko
Lung infection with {gamma}-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice
Am J Physiol Lung Cell Mol Physiol,
November 1, 2005;
289(5):
L711 - L721.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the European Respiratory Society.
|